RGD DISEASE ONTOLOGY - ANNOTATIONS
RGD uses the Human Disease Ontology (DO, https://disease-ontology.org/) for disease curation across species. RGD automatically downloads each new release of the ontology on a monthly basis. Some additional terms which are required for RGD's curation purposes but are not currently covered in the official version of DO have been added. As corresponding terms are added to DO, these custom terms are retired and the DO terms substituted in existing annotations and subsequently used for curation.
Term: tongue squamous cell carcinoma
Accession: DOID:0050865
browse the term
Definition: A head and neck squamous cell carcinoma that is located_in the tongue. (DO)
Synonyms: exact_synonym: SCCT
primary_id: RDO:9000054
xref: EFO:1000055 ; NCI:C4648
G
Ada
adenosine deaminase
ISO
protein:increased activity:saliva:
RGD
PMID:20379753
RGD:152995262
NCBI chr 2:163,565,703...163,592,154
Ensembl chr 2:163,568,504...163,592,159
G
Adipoq
adiponectin, C1Q and collagen domain containing
disease_progression
ISO
protein:decreased expression:serum
RGD
PMID:23181352
RGD:8694469
NCBI chr16:22,965,286...22,976,718
Ensembl chr16:22,965,286...22,976,778
G
Bcl2
B cell leukemia/lymphoma 2
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 1:106,465,906...106,642,020
Ensembl chr 1:106,465,908...106,642,004
G
Birc2
baculoviral IAP repeat-containing 2
exacerbates
ISO
protein:increased expression:tongue (human)
RGD
PMID:18621506
RGD:153323319
NCBI chr 9:7,818,227...7,837,123
Ensembl chr 9:7,818,228...7,837,065
G
Brinp3
bone morphogenetic protein/retinoic acid inducible neural specific 3
ISO
mRNA:decreased expression:tongue:
RGD
PMID:19787213
RGD:14398487
NCBI chr 1:146,371,367...146,778,210
Ensembl chr 1:146,370,498...146,778,210
G
Cav2
caveolin 2
ISO
protein:increased expression:mucosa of tongue
RGD
PMID:20558341
RGD:8661771
NCBI chr 6:17,281,184...17,289,129
Ensembl chr 6:17,281,184...17,289,114
G
Ccnd1
cyclin D1
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 7:144,483,668...144,493,568
Ensembl chr 7:144,483,668...144,493,662
G
Cdkn1a
cyclin dependent kinase inhibitor 1A
disease_progression
ISO
RGD
PMID:12162767
RGD:8662376
NCBI chr17:29,309,953...29,319,696
Ensembl chr17:29,309,950...29,319,701
G
Cxcl15
C-X-C motif chemokine ligand 15
ISO
mRNA:increased expression:head, neck (human)
RGD
PMID:31452775
RGD:150520018
NCBI chr 5:90,942,393...90,950,926
Ensembl chr 5:90,942,393...90,950,926
G
Egfr
epidermal growth factor receptor
treatment
IMP
RGD
PMID:19380367
RGD:8551769
NCBI chr11:16,700,153...16,868,158
Ensembl chr11:16,702,203...16,868,158
G
Erbb3
erb-b2 receptor tyrosine kinase 3
disease_progression
ISO
RGD
PMID:19691460
RGD:126781771
NCBI chr10:128,403,392...128,425,504
Ensembl chr10:128,403,392...128,425,521
G
Erbb4
erb-b2 receptor tyrosine kinase 4
severity
ISO
RGD
PMID:19691460
RGD:126781771
NCBI chr 1:68,071,063...69,147,756
Ensembl chr 1:68,071,345...69,147,218
G
Fancb
Fanconi anemia, complementation group B
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr X:163,763,678...163,780,266
Ensembl chr X:163,763,588...163,780,268
G
Fancc
Fanconi anemia, complementation group C
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr13:63,452,519...63,645,126
Ensembl chr13:63,432,857...63,645,092
G
Fancf
Fanconi anemia, complementation group F
ISO
mRNA:decreased expression:tongue:
RGD
PMID:17409780
RGD:11049143
NCBI chr 7:51,510,325...51,512,015
Ensembl chr 7:51,510,325...51,512,015
G
Fancg
Fanconi anemia, complementation group G
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr 4:43,002,337...43,010,565
Ensembl chr 4:43,002,343...43,010,506
G
Fanci
Fanconi anemia, complementation group I
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr 7:79,042,056...79,100,013
Ensembl chr 7:79,041,677...79,100,012
G
Fancl
Fanconi anemia, complementation group L
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr11:26,337,084...26,421,883
Ensembl chr11:26,336,135...26,421,876
G
Fancm
Fanconi anemia, complementation group M
ISO
RGD
PMID:17409780
RGD:11049143
NCBI chr12:65,120,884...65,178,616
Ensembl chr12:65,122,377...65,178,832
G
Fos
FBJ osteosarcoma oncogene
ISO
mRNA,protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr12:85,520,664...85,524,048
Ensembl chr12:85,520,664...85,524,047
G
Fosb
FBJ osteosarcoma oncogene B
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 7:19,036,621...19,043,970
Ensembl chr 7:19,036,621...19,043,976
G
Fosl1
fos-like antigen 1
ISO
protein:decreased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr19:5,497,726...5,505,966
Ensembl chr19:5,497,575...5,505,974
G
Fosl2
fos-like antigen 2
ISO
mRNA,protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 5:32,292,599...32,315,184
Ensembl chr 5:32,293,145...32,315,186
G
Fubp1
far upstream element (FUSE) binding protein 1
exacerbates
ISO
mRNA, protein:increased expression:tongue (human)
RGD
PMID:32339054
RGD:151361191
NCBI chr 3:151,916,059...151,942,467
Ensembl chr 3:151,916,059...151,942,463
G
Gja1
gap junction protein, alpha 1
ISO
protein:decreased expression:epithelium
RGD
PMID:23568744
RGD:8662380
NCBI chr10:56,253,297...56,266,519
Ensembl chr10:56,253,426...56,278,609
G
Hgf
hepatocyte growth factor
ISO
protein:increased expression:tongue:
RGD
PMID:20848408
RGD:8548612
NCBI chr 5:16,758,493...16,827,448
Ensembl chr 5:16,758,493...16,825,150
G
Ifng
interferon gamma
disease_progression
ISO
protein:decreased expression:serum:
RGD
PMID:17338814
RGD:8662972
NCBI chr10:118,276,951...118,281,799
Ensembl chr10:118,276,951...118,281,797
G
Il10
interleukin 10
disease_progression
ISO
protein:increased expression:serum:
RGD
PMID:17338814
RGD:8662972
NCBI chr 1:130,947,459...130,952,707
Ensembl chr 1:130,947,582...130,952,711
G
Il1rl1
interleukin 1 receptor-like 1
disease_progression
ISO
RGD
PMID:25193287
RGD:39938972
NCBI chr 1:40,444,105...40,504,575
Ensembl chr 1:40,468,730...40,504,575
G
Il2
interleukin 2
ISO
protein:decreased expression:serum:
RGD
PMID:17338814
RGD:8662972
NCBI chr 3:37,174,862...37,180,103
Ensembl chr 3:37,174,672...37,180,108
G
Il33
interleukin 33
disease_progression
ISO
RGD
PMID:25193287
RGD:39938972
NCBI chr19:29,902,513...29,938,118
Ensembl chr19:29,902,514...29,938,118
G
Jak3
Janus kinase 3
disease_progression
ISO
RGD
PMID:26860129
RGD:11531126
NCBI chr 8:72,129,027...72,143,221
Ensembl chr 8:72,128,940...72,143,219
G
Jun
jun proto-oncogene
ISO
mRNA,protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 4:94,937,273...94,940,459
Ensembl chr 4:94,937,271...94,940,459
G
Junb
jun B proto-oncogene
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 8:85,703,538...85,705,377
Ensembl chr 8:85,701,113...85,705,347
G
Jund
jun D proto-oncogene
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 8:71,150,389...71,153,265
Ensembl chr 8:71,151,599...71,153,265
G
Kdr
kinase insert domain protein receptor
treatment
IMP
RGD
PMID:19380367
RGD:8551769
NCBI chr 5:76,093,487...76,139,880
Ensembl chr 5:76,093,487...76,139,118
G
Map2k4
mitogen-activated protein kinase kinase 4
ISO
mRNA:increased expression:tongue squamous epithelium (human)
RGD
PMID:28319306
RGD:150429750
NCBI chr11:65,579,070...65,679,185
Ensembl chr11:65,579,069...65,679,123
G
Met
met proto-oncogene
ISO
protein:increased expression:tongue:
RGD
PMID:20848408
RGD:8548612
NCBI chr 6:17,463,351...17,573,979
Ensembl chr 6:17,463,799...17,573,979
G
Mmp9
matrix metallopeptidase 9
ISO
protein:increased expression:tongue (human)
RGD
PMID:26581505
RGD:11535375
NCBI chr 2:164,782,246...164,797,770
Ensembl chr 2:164,782,700...164,797,770
G
Mtus1
mitochondrial tumor suppressor 1
disease_progression
ISO
RGD
PMID:22153618
RGD:25330347
NCBI chr 8:41,443,949...41,587,318
Ensembl chr 8:41,443,951...41,586,763
G
Slc1a5
solute carrier family 1 (neutral amino acid transporter), member 5
disease_progression
ISO
RGD
PMID:24762957
RGD:151361157
NCBI chr 7:16,515,259...16,532,199
Ensembl chr 7:16,515,265...16,532,199
G
Slc3a2
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
disease_progression
ISO
RGD
PMID:24762957
RGD:151361157
NCBI chr19:8,684,931...8,700,733
Ensembl chr19:8,684,246...8,700,733
G
Slc7a11
solute carrier family 7 (cationic amino acid transporter, y+ system), member 11
severity
ISO
RGD
PMID:24762957
RGD:151361157
NCBI chr 3:50,319,385...50,403,947
Ensembl chr 3:49,846,975...50,398,063
G
Slc7a5
solute carrier family 7 (cationic amino acid transporter, y+ system), member 5
disease_progression
ISO
RGD
PMID:24762957
RGD:151361157
NCBI chr 8:122,607,885...122,634,425
Ensembl chr 8:122,607,889...122,634,433
G
Sox2
SRY (sex determining region Y)-box 2
disease_progression
ISO
RGD
PMID:21689966
RGD:8661665
NCBI chr 3:34,704,144...34,706,610
Ensembl chr 3:34,704,554...34,706,610
G
Trp53
transformation related protein 53
ISO
protein:increased expression:tongue:
RGD
PMID:20385474
RGD:8547851
NCBI chr11:69,471,174...69,482,699
Ensembl chr11:69,471,185...69,482,699
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all